Detailed answers about PHARMAHEALTHTALK COMMUNITY INTEREST COMPANY, including incorporation, status, business activity, and accounts information.
When was PHARMAHEALTHTALK COMMUNITY INTEREST COMPANY founded?
PHARMAHEALTHTALK COMMUNITY INTEREST COMPANY was officially incorporated on 11 November 2019 and is registered under company number 12308840. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is PHARMAHEALTHTALK COMMUNITY INTEREST COMPANY?
Community Interest Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations.
What is the current status of PHARMAHEALTHTALK COMMUNITY INTEREST COMPANY?
PHARMAHEALTHTALK COMMUNITY INTEREST COMPANY's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does PHARMAHEALTHTALK COMMUNITY INTEREST COMPANY do?
PHARMAHEALTHTALK COMMUNITY INTEREST COMPANY operates in the following sectors: 74909 - Other professional, scientific and technical activities n.e.c., 85600 - Educational support services, 86900 - Other human health activities. These SIC codes provide insight into the company's business activities and industry focus.
What is PHARMAHEALTHTALK COMMUNITY INTEREST COMPANY's registered address?
The registered office address of PHARMAHEALTHTALK COMMUNITY INTEREST COMPANY is 6 SAPLING CRESCENT, LIVERPOOL, UNITED KINGDOM, L32 3AA. This is the official address filed with Companies House for legal and statutory correspondence.
Is PHARMAHEALTHTALK COMMUNITY INTEREST COMPANY financially stable?
The most recent accounts for PHARMAHEALTHTALK COMMUNITY INTEREST COMPANY were made up to 7 December 2024, filed as TOTAL EXEMPTION FULL. Next accounts are due by 31 August 2026.